December 29, 2025

Veeva Systems Inc. (VEEV) Stock Analysis: A 38.96% Potential Upside Attracts Investors

Investors eyeing opportunities in the healthcare technology sector might find Veeva Systems Inc. (NYSE: VEEV) an intriguing prospect. As a cloud-based software provider specializing in solutions..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 4.61% Dividend Yield and Growth Outlook

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $111.23..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Challenging Landscape with a 22% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is at a pivotal juncture as it navigates a challenging financial landscape. With a market..

Cencora, Inc. (COR) Stock Analysis: Exploring a 13.75% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, particularly in medical distribution, is capturing investor attention with a significant market cap of $66.16..

Novartis AG (NVS) Stock Analysis: Navigating a Stable Path Amidst Healthcare Giants

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, continues to draw investor attention with its robust market position and expansive pharmaceutical portfolio. Headquartered..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Navigating a 14% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, stands out for investors seeking exposure to the pharmaceutical industry. With a market..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Discovering a 23.89% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is capturing investor attention with its robust growth potential and strategic position in the healthcare sector. With a market cap of..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Insulet Corporation (PODD) Stock Analysis: Robust Analyst Ratings Signal a Promising 30.87% Upside

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, focusing on innovative medical devices. With a market capitalization of $20.32 billion, the company..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Powerhouse with a Promising 3.99% Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a stalwart in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of..

Natera, Inc. (NTRA) Investor Outlook: Analysts Back Diagnostics Leader with a 5.36% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its innovative molecular testing services. Headquartered..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 19.96% Potential Upside for Investors

As an iconic name in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) stands at the forefront of health technology, offering a diverse portfolio that spans..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring an 18% Upside Potential

Labcorp Holdings Inc. (NYSE: LH) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly within the diagnostics and research industry...

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a Robust Biotech with 1.33% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology sector, is capturing investor attention with its robust portfolio of medicines and innovative research initiatives...

Centene Corporation (CNC) Investor Outlook: Navigating Healthcare Challenges with a $19.91 Billion Market Cap

Centene Corporation (NYSE: CNC), a key player in the healthcare sector, continues to navigate a complex landscape as a provider of healthcare plans in the United..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 81% Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical pioneer based in Miami, Florida, has captured investor attention with an impressive potential upside of 81.28%. Specializing in the..

BeOne Medicines Ltd. (ONC) Stock Analysis: Discovering a 28% Upside in the Biotech Sector

Investors eyeing the healthcare sector have a promising candidate in BeOne Medicines Ltd. (ONC), a biotechnology firm based in Switzerland, with a substantial market capitalization of..

Sanofi (SNY) Investor Outlook: Exploring a 22.45% Upside in a Challenging Market

Sanofi (NYSE: SNY), a titan in the global healthcare sector, is a noteworthy player in the drug manufacturing industry. With a rich history dating back to..

Merck & Company, Inc. (MRK) Stock Analysis: Robust Dividend and Promising Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to attract investor attention due to its significant market presence and robust financial..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 12.57% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector specializing in diagnostics and research, is drawing attention from investors due to its robust market..

Search

Funds

December 29, 2025

Search

Funds

December 29, 2025

FTSE 100

Funds